But DSIP is not automatically the right answer
Any dosing protocols are determined exclusively within authorised clinical trials or regulated research settings
The parenteral GLP-1 receptor agonist market is projected to grow by $47,567 million, the GLP-1 receptor agonists for hospitals market by $43,598 million, and the semaglutide-based GLP-1 receptor agonist market by $38,238 million over the next five years from 2025 to 2030
If you have a B-12 deficiency, it can be more challenging to lose weight, and you might feel sluggish or tired, so B-12 injections can help boost your energy and metabolism.
Our dedicated medical team takes the time to educate and guide you, ensuring you understand the difference between naturally occurring GLP-1 and pharmaceutical interventions designed to enhance your health
They will work with you to develop a personalized treatment plan to support your long-term wellness goals